Search Results 21-30 of 17049 for Plasmacytoma
Extramedullary disease defined as Plasmacytoma outside bone marrow that is not contiguous with a bone lesion with at least one lesion that has a single diameter ...
Subjects with solitary plasmacytoma; active or history of plasma cell leukemia (PCL); Waldenstrom's macroglobulinemia; POEMS syndrome (Polyneuropathy ...
March is Multiple Myeloma Awareness Month. Multiple myeloma is a cancer of a type of white blood cell called a plasma cell in the bone marrow.
Measurable plasmacytoma; if plasmacytoma measurement is the only measurable disease, subject eligibility must be reviewed with lead principal investigator ...
... plasmacytoma (should be measured within 28 days of Screening Visit); Failed at least 1 line of systemic therapy. The preparative regimen (with or without ...
... plasmacytoma AND one or more of the following CRAB features: a. Evidence of end organ damage that can be attributed to the underlying plasma cell ...
... plasmacytoma and measurable disease as defined by any of the following: (a) immunoglobulin (Ig) G myeloma (serum monoclonal paraprotein [M-protein] level > ...
Prior therapy for the treatment of solitary plasmacytoma is permitted, but > 7 days should have elapsed from the last day of radiation. NOTE: Prior therapy ...
In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Rather than produce helpful antibodies, the cancer ...
Learn about this cancer that forms in the bone and bone marrow. Treatments include medications and bone marrow transplant.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!